<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609698</url>
  </required_header>
  <id_info>
    <org_study_id>AJOU-CV-0001</org_study_id>
    <nct_id>NCT02609698</nct_id>
  </id_info>
  <brief_title>ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)</brief_title>
  <official_title>A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B. Braun Korea Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <brief_summary>
    <textblock>
      This clinical trial studies patients treated with the Coroflex ISAR Stent for coronary artery
      disease in order for the objective of verifying the non-inferiority of results that among
      patients who were administered DAPT for 3 months compared to patients who were administered
      DAPT for 6 months, in terms of the efficacy and safety of DAPT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>12 months from the time of the stenting</time_frame>
    <description>Major Adverse Cardiac Events (MACE) (cardiac death, recurrent myocardial infarction, target lesion revascularization) at 12 months from the time of the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>6 months from the time of the stenting</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any death, cardiac death, MI, TLR, TVR</measure>
    <time_frame>6 months from the time of the stenting</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any death, cardiac death, MI, Stroke, TLR, TVR</measure>
    <time_frame>12 months from the time of the stenting</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">906</enrollment>
  <condition>Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Coroflex ISAR 3 months DAPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have received a Coroflex ISAR stent procedure to treat coronary arterial lesions, and administered the drug for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coroflex ISAR 6 months DAPT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who have received a Coroflex ISAR stent procedure to treat coronary arterial lesions, and administered the drug for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coroflex ISAR</intervention_name>
    <description>This stent platform has a thin-strut cobalt-chromiun alloy backbone, no polymer, microporous surface.</description>
    <arm_group_label>Coroflex ISAR 3 months DAPT</arm_group_label>
    <arm_group_label>Coroflex ISAR 6 months DAPT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>3 months DAPT</intervention_name>
    <arm_group_label>Coroflex ISAR 3 months DAPT</arm_group_label>
    <other_name>Aspirin + clopidogrel for 3-months schedule after the coronary stenting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>6 months DAPT</intervention_name>
    <arm_group_label>Coroflex ISAR 6 months DAPT</arm_group_label>
    <other_name>Aspirin + clopidogrel for 6-months schedule after the coronary stenting</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aged 19 or older

          2. Patients who have submitted a written consent to participate in the clinical trial

          3. De novo lesion

          4. Patients scheduled for elective intervention to treat ischemic cardiovascular disease

        Exclusion Criteria:

          1. Patients with any contraindications or hypersensitivity related to antiplatelet
             therapy

          2. Patients with Acute Myocardial Infarction (ST elevation myocardial infarction, Non ST
             elevation myocardial infarction)

          3. Patients who are anticipated to receive treatment or surgery that may require
             desisting the administration of antiplatelet therapy for 2 weeks or longer during the
             period of the clinical trial

          4. Chronic total occlusion (CTO) lesions, in-stent restenosis (ISR)

          5. Patients experiencing cardiogenic shock

          6. Women who are breastfeeding, pregnant, or desiring pregnancy

          7. Patients with findings of hemorrhage

          8. Patients with a life expectancy of less than 1 year

          9. Patients who have received a drug-eluting stent (DES) procedure within the past 6
             months

         10. Any other patients judged by the investigator to be unsuitable for the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myeong-Ho Yoon, Ph.D, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Center, Ajou University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Myeong-Ho Yoon, Ph.D, MD</last_name>
    <phone>+82-31-219-4329</phone>
    <email>yoonmh65@hanmail.net,</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Yeongtong-gu</city>
        <state>Suwon</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myeong-Ho Yoon, Ph.D, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 18, 2015</last_update_submitted>
  <last_update_submitted_qc>November 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Myeong-Ho Yoon</investigator_full_name>
    <investigator_title>Professor, Dept of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Stent</keyword>
  <keyword>Polymer-free</keyword>
  <keyword>Antiplatelet therapy</keyword>
  <keyword>Clopidogrel</keyword>
  <keyword>DES</keyword>
  <keyword>DAPT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Ticlopidine</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

